Simon, Christopher Haemonetics Corp (HAE) insider trading activity

Simon, Christopher is President & CEO of HAEMONETICS CORP. Currently has a direct ownership of 322,838 shares of HAE, which is worth approximately $25 Million. The most recent transaction as insider was on Aug 29, 2024, when has been sold 39,704 shares (Common Stock) at a price of $75.56 per share, resulting in proceeds of $3,000,034. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 323K

0% 3M change

8.9% 12M change

Total Value Held $25 Million

Simon, Christopher Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 29 2024	SELL Other acquisition or disposition	$3,000,034 $75.56 p/Share	39,704 Reduced 10.95%	322,838 Common Stock
Jun 06 2024	SELL Payment of exercise price or tax liability	$6,233,252 $87.38 p/Share	71,335 Reduced 16.44%	362,542 Common Stock
Jun 06 2024	BUY Exercise of conversion of derivative security	$4,352,046 $41.64 p/Share	104,516 Added 19.41%	433,877 Common Stock
May 28 2024	SELL Payment of exercise price or tax liability	$3,995,387 $95.73 p/Share	41,736 Reduced 11.25%	329,361 Common Stock
May 28 2024	BUY Grant, award, or other acquisition	-	106,062 Added 22.23%	371,097 Common Stock
May 17 2024	SELL Payment of exercise price or tax liability	$386,462 $95.73 p/Share	4,037 Reduced 1.59%	250,411 Common Stock
May 17 2024	BUY Grant, award, or other acquisition	-	14,624 Added 5.23%	265,035 Common Stock
May 16 2024	SELL Payment of exercise price or tax liability	$180,783 $94.8 p/Share	1,907 Reduced 0.74%	254,448 Common Stock
May 15 2024	SELL Payment of exercise price or tax liability	$142,805 $96.49 p/Share	1,480 Reduced 0.57%	256,355 Common Stock
Mar 11 2024	SELL Bona fide gift	-	38,900 Reduced 13.12%	257,546 Common Stock
Jun 29 2023	SELL Payment of exercise price or tax liability	$9,982,868 $84.84 p/Share	117,667 Reduced 28.41%	296,446 Common Stock
Jun 29 2023	BUY Exercise of conversion of derivative security	$5,628,903 $28.61 p/Share	196,746 Added 32.21%	414,113 Common Stock
May 18 2023	SELL Payment of exercise price or tax liability	$319,942 $83.34 p/Share	3,839 Reduced 1.74%	217,367 Common Stock
May 16 2023	SELL Payment of exercise price or tax liability	$141,487 $89.21 p/Share	1,586 Reduced 0.71%	221,206 Common Stock
May 15 2023	BUY Grant, award, or other acquisition	-	18,225 Added 7.56%	222,792 Common Stock
May 12 2023	SELL Payment of exercise price or tax liability	$75,288 $88.16 p/Share	854 Reduced 0.42%	204,567 Common Stock
Nov 11 2022	SELL Bona fide gift	-	8,600 Reduced 4.02%	205,124 Common Stock
Jun 13 2022	SELL Open market or private sale	$71,865 $62.6 p/Share	1,148 Reduced 0.53%	213,724 Common Stock
May 19 2022	SELL Open market or private sale	$147,514 $59.1 p/Share	2,496 Reduced 1.15%	214,872 Common Stock
May 16 2022	SELL Open market or private sale	$46,675 $56.1 p/Share	832 Reduced 0.43%	191,327 Common Stock
May 16 2022	BUY Grant, award, or other acquisition	-	26,041 Added 10.7%	217,368 Common Stock
Jun 14 2021	SELL Open market or private sale	$71,844 $59.87 p/Share	1,200 Reduced 0.62%	191,806 Common Stock
Jun 07 2021	SELL Open market or private sale	$149,569 $55.09 p/Share	2,715 Reduced 1.39%	193,006 Common Stock
May 19 2021	SELL Open market or private sale	$56,515 $55.19 p/Share	1,024 Reduced 0.52%	195,721 Common Stock
May 18 2021	BUY Grant, award, or other acquisition	-	26,515 Added 11.88%	196,745 Common Stock

Simon, Christopher

President & CEO

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HAE shares.

Notify only if

Value

Insider Trading

Get notified when an Haemonetics Corp insider buys or sells HAE shares.

Notify only if

Operation

Value

Type

News

Receive news related to HAEMONETICS CORP

Track Activities on HAE

Account